DLA Piper’s broad offering regularly handles cross-border joint ventures, private equity investment mandates, and clinical trial agreements for its lucrative, global client base of pharma and biotech companies. Practice head Roberto Valenti is well-equipped to assist clients with the full range of soft IP disputes and commercial issues surrounding medical devices. Marco de Morpurgo divides his time between Rome and Brussels, with his primary area of expertise being EU and Italian regulation of biotech, medical devices, and pharma products. Raffaella Quintana stands out due to her longstanding expertise in internal investigations and commercial fraud matters within the life sciences space, often representing pharma companies, while regulatory expert Nicola Landolfi is known for his vast knowledge of both EU and Italian law governing the licensing of products and clinical trials.
Legal 500 redaktioneller Kommentar
Auszeichnungen
Mandantenzufriedenheit
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- 'Very well-prepared and skilled.'
- 'Roberto Valenti is very prepared and talented in understanding issues and favouring solutions.'
- 'Competence, professionalism, punctuality, preparation, and in-depth knowledge of the subject matter are all aspects that distinguish DLA Piper from others.'
- 'People are always available and prepared.'
Kernmandanten
- Pfizer Italia S.r.l.
- Pfizer S.r.l.
- Wyeth Lederle S.r.l.
- Eli Lilly
- Iovance Biotherapeutics
- Vertex Pharmaceuticals
- MD Italy
- Sifi
- Menarini Group
- Medtronic
Highlight-Mandate
- Assisted the Pfizer Group in relation to all aspects of Italian law relating to the integration of Seagen's Italian business into Pfizer's Italian business, completed by means of the merger by incorporation of Seagen Italy S.r.l. with and into Pfizer S.r.l.
- Assisting Sifi S.p.A. with respect to the licence agreement with Affamed and to the entrance and establishment of the joint venture in the Chinese market, including the shareholder agreement.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Führende Associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Praxisleitung
Roberto Valenti
Weitere Kernanwält*innen
Marco de Morpurgo; Raffaella Quintana; Gualtiero Dragotti; Nicola Landolfi